These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 15539707)

  • 1. Levels and values of serum high-sensitivity C-reactive protein within 6 hours after the onset of acute myocardial infarction.
    Yip HK; Wu CJ; Chang HW; Yang CH; Yeh KH; Chua S; Fu M
    Chest; 2004 Nov; 126(5):1417-22. PubMed ID: 15539707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Level of high-sensitivity C-reactive protein is predictive of 30-day outcomes in patients with acute myocardial infarction undergoing primary coronary intervention.
    Yip HK; Hang CL; Fang CY; Hsieh YK; Yang CH; Hung WC; Wu CJ
    Chest; 2005 Mar; 127(3):803-8. PubMed ID: 15764760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The significance of admission hs-CRP in patients undergoing primary percutaneous intervention for acute myocardial infarction].
    Cağli KE; Topaloğlu S; Aras D; Günel EN; Ozlü MF; Uygur B; Baysal E; Sen N
    Turk Kardiyol Dern Ars; 2009 Jan; 37(1):19-25. PubMed ID: 19225249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-reactive protein and coronary artery disease.
    Auer J; Berent R; Lassnig E; Eber B
    Jpn Heart J; 2002 Nov; 43(6):607-19. PubMed ID: 12558125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time-dependent changes of hs-CRP serum concentration in patients with non-ST elevation acute coronary syndrome.
    Jahn J; Hellmann I; Maass M; Giannitsis E; Dalhoff K; Katus HA
    Herz; 2004 Dec; 29(8):795-801. PubMed ID: 15599677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High sensitive C-reactive protein and the risk of acute kidney injury among ST elevation myocardial infarction patients undergoing primary percutaneous intervention.
    Shacham Y; Leshem-Rubinow E; Steinvil A; Keren G; Roth A; Arbel Y
    Clin Exp Nephrol; 2015 Oct; 19(5):838-43. PubMed ID: 25492251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of dynamic cardiac troponin I concentrations and C-reactive protein in the monitoring of myocardial infarction in patients with repeated myocardial infarction].
    Plak M; Orliński L; Łobos M; Ciesielczyk M; Wlazeł RN; Paradowski MT
    Pol Merkur Lekarski; 2010 Jun; 28(168):444-9. PubMed ID: 20642101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time-dependent prognostic effect of high sensitivity C-reactive protein with statin therapy in acute myocardial infarction.
    Kang DO; Park Y; Seo JH; Jeong MH; Chae SC; Ahn TH; Jang WY; Kim W; Park EJ; Choi BG; Na JO; Choi CU; Kim EJ; Rha SW; Park CG; Seo HS;
    J Cardiol; 2019 Jul; 74(1):74-83. PubMed ID: 30745001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of serum high-sensitivity C-reactive protein and interleukin-6 in patients with acute coronary syndrome.
    Wang XH; Liu SQ; Wang YL; Jin Y
    Genet Mol Res; 2014 Jun; 13(2):4260-6. PubMed ID: 25036169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated levels of oxidized low-density lipoprotein correlate positively with C-reactive protein in patients with acute coronary syndrome.
    Zhang YC; Wei JJ; Wang F; Chen MT; Zhang MZ
    Cell Biochem Biophys; 2012 Mar; 62(2):365-72. PubMed ID: 21947962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baseline systemic inflammatory status and no-reflow phenomenon after percutaneous coronary angioplasty for acute myocardial infarction.
    Niccoli G; Lanza GA; Spaziani C; Altamura L; Romagnoli E; Leone AM; Fusco B; Trani C; Burzotta F; Mazzari MA; Mongiardo R; Biasucci LM; Rebuzzi AG; Crea F
    Int J Cardiol; 2007 May; 117(3):306-11. PubMed ID: 16859772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of preprocedure high-sensitivity C-reactive protein to predict death, recurrent myocardial infarction, and stent thrombosis according to stent type in patients with ST-segment elevation myocardial infarction randomized to bare metal or drug-eluting stenting during primary percutaneous coronary intervention.
    Schoos MM; Kelbæk H; Kofoed KF; Køber L; Kløvgaard L; Helqvist S; Engstrøm T; Saunamäki K; Jørgensen E; Holmvang L; Clemmensen P
    Am J Cardiol; 2011 Jun; 107(11):1597-603. PubMed ID: 21439539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased C-reactive protein level after coronary stent implantation in patients with stable coronary artery disease.
    Almagor M; Keren A; Banai S
    Am Heart J; 2003 Feb; 145(2):248-53. PubMed ID: 12595841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of aspirin plus clopidogrel on inflammatory markers in patients with non-ST-segment elevation acute coronary syndrome.
    Chen YG; Xu F; Zhang Y; Ji QS; Sun Y; Lü RJ; Li RJ
    Chin Med J (Engl); 2006 Jan; 119(1):32-6. PubMed ID: 16454979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin therapy to reduce stent thrombosis in acute myocardial infarction patients with elevated high-sensitivity C-reactive protein.
    Jeong HC; Ahn Y; Hong YJ; Kim JH; Jeong MH; Kim YJ; Chae SC; Cho MC;
    Int J Cardiol; 2013 Sep; 167(5):1848-53. PubMed ID: 22592028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of plaque rupture and elevated C-reactive protein on clinical outcome in patients with acute myocardial infarction: an intravascular ultrasound study.
    Hong YJ; Mintz GS; Kim SW; Okabe T; Bui AB; Pichard AD; Satler LF; Waksman R; Weissman NJ
    J Invasive Cardiol; 2008 Sep; 20(9):428-35. PubMed ID: 18762670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation of neutrophil/lymphocyte ratio to coronary flow to in-hospital major adverse cardiac events in patients with ST-elevated myocardial infarction undergoing primary coronary intervention.
    Akpek M; Kaya MG; Lam YY; Sahin O; Elcik D; Celik T; Ergin A; Gibson CM
    Am J Cardiol; 2012 Sep; 110(5):621-7. PubMed ID: 22608360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-reactive protein and lesion morphology in patients with acute myocardial infarction.
    Sano T; Tanaka A; Namba M; Nishibori Y; Nishida Y; Kawarabayashi T; Fukuda D; Shimada K; Yoshikawa J
    Circulation; 2003 Jul; 108(3):282-5. PubMed ID: 12835218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between C-reactive protein level and echocardiography assessed left ventricular function in first ST-segment elevation myocardial infarction patients who underwent primary coronary intervention.
    Shacham Y; Topilsky Y; Leshem-Rubinow E; Arbel Y; Ben Assa E; Keren G; Roth A; Steinvil A
    J Cardiol; 2014 Jun; 63(6):402-8. PubMed ID: 24299986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between serum level of high-sensitive C-reactive protein and extension of myocardial involvement in patients with acute myocardial infarction.
    Rashidinejad H; Hosseini SM; Moazenzadeh M; Azimzadeh BS; Mirzaeipour F; Fakhreddini K; Sheikhvatan M
    Rom J Intern Med; 2012; 50(3):211-5. PubMed ID: 23330288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.